A total of 10 individuals with HIV have been cured to date. Most of these patients have remained anonymous, but three have ...

For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating—and possibly even ...

For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating-and possibly even ...

For more than 20 years, the Duke Consortia for HIV/AIDS Vaccine Development had conducted its groundbreaking research with ...

President Yoweri Museveni has indicated that the Ugandan economy will reap big from the knowledge economy, that includes ...

Gilead offers a meaningful upside opportunity should it execute on increasing revenue growth to the low-to-middle single ...

From influenza and COVID-19 to HIV, viruses continue to pose a serious danger to global health. But just as pressing are ...

Shares in Moderna and BioNTech have imploded since their 2021 peaks, shaving billions of dollars from their founders’ ...

Some everyday causes of fatigue may include: Poor sleep habits: Inconsistent sleep schedules, screen time before bed, and ...

Gilead Sciences, Inc. GILD, one of the top biotech companies, has put up a robust performance so far in 2025. Shares of the ...

A groundbreaking injectable drug, lenacapavir, offers renewed hope in the fight against HIV. Set to be available in 2027 in over 100 low and middle-income countries at an affordable price of $40 per ...